1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Idogen AB (publ)
  6. Company
    IDOGEN   SE0014428561

IDOGEN AB (PUBL)

(IDOGEN)
  Report
Delayed Nasdaq Stockholm  -  05/16 11:29:35 am EDT
0.5140 SEK   -0.39%
05/04Idogen publishes interim report for 1 January - 31 March 2022
AQ
05/04Idogen AB Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/19Idogen Receives Approval From Swedish, Norwegian Authorities For Clinical Trial Of Hemophilia Treatment
MT
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Business Summary
Idogen AB is a Sweden-based company engaged in the healthcare industry. The Company is a research-driven entity developing a so called Tolerogenic Vaccine, a treatment concept for anti-drug antibodies, autoimmune diseases and transplant rejection. Its treatment is based on the patient's own dendritic cells (a type of white blood cell) and is taken out and reprogrammed in vitro and then given back to the patient. The Company is in pre-clinical phase and owns a platform technology, from which Idogen AB develops treatment for anti-drug antibodies, as well as autoimmune diseases that cannot be cured. In addition, the Company focuses on the transplantation market by reducing the need for immunosuppressive therapy after transplantation.

Number of employees : 10 people.
Managers
Name Title Age Since
Anders Eric Karlsson Chief Executive Officer 56 2019
Rolf Ingvar Karlsson Lenart Chief Financial Officer - -
Dennis Bang Henriksen, Dr. Chief Technology Officer 59 -
┼sa Schi÷tt, Dr. Chief Scientific Officer - 2020
Christina Brattstr÷m Chief Marketing Officer - 2020
Neil Thomas, Dr. Chief Business Officer - 2014
Vicki Venizelos Chief Regulatory Officer - 2020
Members of the board
Name Title Age Since
Eva Agneta Edberg Chairman 65 -
Leif-G÷ran Salford Independent Director 80 2008
Christina Elisabeth Herder, Dr. Independent Director 60 2017
Sharon Longhurst Independent Director - 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 72,507,205 66,894,083 92.3% 0 0.0% 92.3%
Company contact information
Idogen AB
Scheelevńgen 2
Medicon Village
Lund, Skane 223 81

Phone : +46.46.2756330
Web : http://www.idogen.se
Brand Portfolio
In partnership withAllbrands.markets
More brands of Idogen AB (publ)